The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
Open accessAbstract
OBJECTIVE: A comprehensive meta-analysis of clinical trial data was performed to assess the possible association of fluoxetine and suicidality (suicidal acts and ideation). DESIGN: Retrospective analysis of pooled data from 17 double blind clinical trials in patients with major depressive disorder comparing fluoxetine (n = 1765) with a tricyclic antidepressant (n = 731) or placebo (n = 569), or both. MAIN OUTCOME MEASURES: Multiple data sources were searched to identify patients with suicidal acts. Suicidal ideation was assessed with item 3 of the Hamilton depression rating scale, which systematically rates suicidality. Emergence of substantial suicidal ideation was defined as a change in the rating of this item from 0 or 1 at baseline to 3 or 4 during double blind treatment; worsening was defined as any increase from baseline; improvement was defined as a decrease from baseline at the last visit during the treatment. RESULTS: Suicidal acts did not differ significantly in comparisons of fluoxetine with placebo (0.2% v 0.2%, p = 0.494, Mantel-Haenszel adjusted incidence difference) and with tricyclic antidepressants (0.7% v 0.4%, p = 0.419). The pooled incidence of suicidal acts was 0.3% for fluoxetine, 0.2% for placebo, and 0.4% for tricyclic antidepressants, and fluoxetine did not differ significantly from either placebo (p = 0.533, Pearson's chi 2) or tricyclic antidepressants (p = 0.789). Suicidal ideation emerged marginally significantly less often with fluoxetine than with placebo (0.9% v 2.6%, p = 0.094) and numerically less often than with tricyclic antidepressants (1.7% v 3.6%, p = 0.102). The pooled incidence of emergence of substantial suicidal ideation was 1.2% for fluoxetine, 2.6% for placebo, and 3.6% for tricyclic antidepressants. The incidence was significantly lower with fluoxetine than with placebo (p = 0.042) and tricyclic antidepressants (p = 0.001). Any degree of worsening of suicidal ideation was similar with fluoxetine and placebo (15.4% v 17.9%, p = 0.196) and with fluoxetine and tricyclic antidepressants (15.6% v 16.3%, p = 0.793). The pooled incidence of worsening of suicidal ideation was 15.3% for fluoxetine, 17.9% for placebo, and 16.3% for tricyclic antidepressants. The incidence did not differ significantly with fluoxetine and placebo (p = 0.141) or tricyclic antidepressants (p = 0.542). Suicidal ideation improved significantly more with fluoxetine than with placebo (72.0% v 54.8%, p less than 0.001) and was similar to the improvement with tricyclic antidepressants (72.5% v 69.8%, p = 0.294). The pooled incidence of improvement of suicidal ideation was 72.2% for fluoxetine, 54.8% for placebo, and 69.8% for tricyclic antidepressants. The incidence with fluoxetine was significantly greater than with placebo (p less than 0.001) and did not differ from that with tricyclic antidepressants (p = 0.296). CONCLUSIONS: Data from these trials do not show that fluoxetine is associated with an increased risk of suicidal acts or emergence of substantial suicidal thoughts among depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Time-related predictors of suicide in major affective disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1189 · Cited by 1,058
Suicidal Feelings in the General Population: A Prevalence Study
Paykel, E. S., Myers, J. K., Lindenthal, J. J., & Tanner, J. (1974) · British Journal of Psychiatry · doi:10.1192/bjp.124.5.460 · Cited by 827
Estimation of a Common Effect Parameter from Sparse Follow-Up Data
Greenland, S., & Robins, J. M. (1985) · Biometrics · doi:10.2307/2530643 · Cited by 794
Suicide and Primary Affective Disorders
Guze, S. B., & Robins, E. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.117.539.437 · Cited by 724
Emergence of intense suicidal preoccupation during fluoxetine treatment
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.207 · Cited by 532
Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up
Simeon, J. G., Dinicola, V. F., Ferguson, H. B., & Copping, W. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90050-q · Cited by 264
A Comparison of Fluoxetine Imipramine and Placebo in Patients with Bipolar Depressive Disorder
COHN, J. B., COLLINS, G., ASHBROOK, E., & WERNICKE, J. F. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198910000-00006 · Cited by 257
Panic Disorder, Comorbidity, and Suicide Attempts
Johnson, J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810210013002 · Cited by 245
Stark, P., & Hardison, C. D. (1985) · PubMed · Cited by 239
Emergence of Self-Destructive Phenomena in Children and Adolescents during Fluoxetine Treatment
KING, R. A., RIDDLE, M. A., CHAPPELL, P. B., HARDIN, M. T., ANDERSON, G. M., LOMBROSO, P., & SCAHILL, L. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199103000-00003 · Cited by 191
Feighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 171
Chouinard, G. (1985) · PubMed · Cited by 157
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Jb, C., & Wilcox, C. M. (1985) · PubMed · Cited by 133
Fixed-dose fluoxetine therapy for depression.
Jf, W., Dunlop, S. R., Dornseif, B. E., & Zerbe, R. L. (1987) · PubMed · Cited by 120
Self-citationA comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients
Muijen, M., Roy, D. H., Silverstone, T., Mehmet, A., & Christie, M. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06353.x · Cited by 110
Low-dose fluoxetine therapy for depression.
Wernicke, J. F., Dunlop, S. R., Dornseif, B. E., Bosomworth, J. C., & Humbert, M. (1988) · PubMed · Cited by 101
Self-citationSuicidal Ideation Related to Fluoxetine Treatment
Masand, P. S., Gupta, S. B., & Dewan, M. J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240616 · Cited by 99
Suicidality and fluoxetine: is there a relationship?
Fava, M., & Rosenbaum, J. F. (1991) · PubMed · Cited by 94
Characteristics of responders to fluoxetine.
Reimherr, F. W., Wood, D. R., Byerley, B., Brainard, J., & Bi, G. (1984) · PubMed · Cited by 82
[Recurrence of unipolar depression and efficacy of maprotiline].
Rouillon, F., Phillips, R., Serrurier, D., Ansart, E., & Mj, G. (1989) · PubMed · Cited by 81
BYERLEY, W. F., REIMHERR, F. W., WOOD, D. R., & GROSSER, B. I. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198804000-00005 · Cited by 80
Paradoxical Worsening of Depressive Symptomatology Caused by Antidepressants
Damluji, N. F., & Ferguson, J. M. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198810000-00007 · Cited by 77
A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
Feighner, J. P. (1985) · PubMed · Cited by 70
Fluoxetine in depressed patients: a comparison with imipramine.
Bremner, J. D. (1984) · PubMed · Cited by 69
Robinson, D. G., & Spiker, D. G. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90013-8 · Cited by 60
Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop, S. R., Dornseif, B. E., Wernicke, J., & Potvin, J. H. (1990) · PubMed · Cited by 59
Self-citationA Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression
Feighner, J. P., Boyer, W. F., Merideth, C., & HENDRICKSON, G. G. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198904000-00004 · Cited by 58
A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
Fabre, L. F., & Putman, H. P. (1987) · PubMed · Cited by 48
Do some antidepressants promote suicide?
Montgomery, S., & Pinder, R. M. (1987) · Psychopharmacology · doi:10.1007/bf00177927 · Cited by 46
Beasley, C. M., Sayler, M. E., Bosomworth, J. C., & Wernicke, J. F. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199106000-00004 · Cited by 46
Self-citationA Comparison of Fluoxetine and Amitriptyline in the Treatment of Major Depression
Keegan, D. A., Bowen, R., Blackshaw, S. L., SALEH, S., Dayal, N., REMILLARD, F., Shrikhande, S., PEREZ, S. C., Boulton, A. L., RICHARDSON, S., et al. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00007 · Cited by 46
Black, D. W., Winokur, G., Mohandoss, E., Woolson, R. F., & Nasrallah, A. T. (1989) · Annals of Clinical Psychiatry · doi:10.3109/10401238909149975 · Cited by 43
Pattern analysis of antidepressant response to fluoxetine.
Rr, F., Goodnick, P. J., Peselow, E. D., Barouche, F., & SCHLEGEL, A. (1986) · PubMed · Cited by 20
Cited by
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
McAuley, L., Pham, B., Tugwell, P., & Moher, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02786-0 · Cited by 812
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
Thase, M. E., Entsuah, A. R., & Rudolph, R. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.3.234 · Cited by 801
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Metadata
- Authors
- Beasley, C. M., Dornseif, B. E., Bosomworth, J. C., Sayler, M. E., Rampey, A. H., Heiligenstein, J. H., Thompson, V. L., Murphy, D. J., & Masica, D. N.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1991-09-21
- Volume
- 303
- Issue
- 6804
- Pages
- 685-692
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1971916547
- Cited by
- 361
- References
- 34
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.